Bradley van Paridon

How do COVID-19 outcomes — such as mortality and disease severity — differ among lung transplant recipients who contracted COVID-19 earlier vs later in the pandemic?

Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?

Researchers developed a model to compare the performance and protective effects of 2 different vaccines against infections caused by varicella-zoster virus.

Researchers conducted a study to assess the effect of COVID-19 vaccination among individuals previously infected with COVID-19.

Researchers evaluated the effect of sarilumab treatment on the outcomes of patients hospitalized with moderate to severe COVID-19 pneumonia.

Investigators conducted a study to determine the accuracy of self-reported taste impairment via psychophysical evaluation in patients with long-haul COVID-19 infection.

Researchers conducted a study to assess the effect of thromboprophylaxis with rivaroxaban following hospital discharge in patients with COVID-19.

Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.

Researchers assessed the characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis who were receiving systemic therapies.

Researchers conducted a study to assess the efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with a seasonal influenza vaccine.